Group 1: Company Announcements - Cambridge Technology currently does not produce chips containing CPO technology [1] - TCL Technology plans to invest 29.5 billion yuan to construct an 8.6-generation printed OLED production line [1] - Huakang Clean has won the bid for the "Medical Service Construction Project" [1] - Aotewei intends to acquire an 8.99% stake in its subsidiary Songci Electromechanical [1] - Shanghai Yizhong plans to repurchase shares worth 30 million to 35 million yuan [1] Group 2: Operational Data - Huadong Co. reported a sales revenue of 338 million yuan from live pigs in August [1] - Tianma Technology has accumulated approximately 11,921.59 tons of eels from January to August [1] Group 3: Shareholding Changes - Mars Man's controlling shareholder and actual controller's concerted actor plans to reduce holdings by no more than 2.94% [2] - Zhiwei Intelligent's actual controller Guo Xuhui intends to reduce holdings by no more than 2.9749% [2] - Donglin Investment plans to reduce holdings in Jin'an Guoji by no more than 2.878% [2] Group 4: Other Financial Activities - Zhonglun New Materials plans to issue convertible bonds to raise no more than 1.068 billion yuan [2] - Tuojing Technology intends to raise no more than 4.6 billion yuan through a private placement [1][2]

Core Viewpoint - Cambridge Technology announced on September 12 that its A-share stock price had deviated by a cumulative increase of 20% over three consecutive trading days, indicating abnormal trading activity [1] Group 1: Company Operations - The company confirmed that there have been no significant changes in its daily operations [1] - The market environment and industry policies affecting the company have not undergone major adjustments [1] - The production costs and sales of various products have not experienced substantial fluctuations, and internal operational order remains normal [1] Group 2: Product Development - The company does not currently produce chips containing CPO technology, and the core components related to CPO, such as the optical engine and external light source (ELSFP), are still in the stages of collaborative research and design, with no business revenue generated yet [1] - The LPO business has sent samples for testing to several major North American clients, but the cumulative order and shipment amount for the first half of 2025 is only about 0.03% of the revenue for the same period, contributing minimally to the company's current performance [1]

Core Viewpoint - The company is currently not producing chips with CPO technology, and its related core components are still in the research and design stages, resulting in no business revenue generated so far [1] Group 1: CPO Technology and Business Impact - The core components related to CPO technology, namely the optical engine and external light source (ELSFP), are in collaborative development and design phases, with no revenue impact yet [1] - The LPO business has sent samples for testing to several major North American clients, but the cumulative orders and shipment amounts for the first half of 2025 will only account for approximately 0.03% of the company's revenue during the same period, indicating minimal contribution to current performance [1] - Investors are advised to view the company's progress in emerging technology fields with rationality and not to overinterpret the short-term impact of these businesses on performance, highlighting the uncertainty risks associated with business implementation [1] Group 2: Shareholder Activity - On August 27, the company's controlling shareholder, Cambridge Industries Company Limited, reduced its holdings by selling 1.8 million shares through a block trade [1]

Group 1 - The company has issued a risk warning regarding its stock trading, stating that it currently does not produce chips containing CPO technology, and that the core components related to CPO, such as the optical engine and external light source (ELSFP), are still in the collaborative research and design stages, with no business revenue generated yet [1] - The LPO business has sent samples for testing to several major North American clients, but the cumulative orders and shipment amounts for the first half of 2025 are expected to account for only about 0.03% of the company's revenue during the same period, indicating minimal contribution to current performance [1] - Investors are advised to rationally view the company's progress in emerging technology fields and not to overinterpret the impact of related businesses on short-term performance, while also being aware of the uncertainties associated with business implementation [1] Group 2 - On August 27, 2025, the company's controlling shareholder, Cambridge Industries Company Limited, reduced its holdings by 1.8 million shares through a block trade [1]

Core Viewpoint - Cambridge Technology has issued a risk warning regarding its stock trading, indicating that the company currently does not produce chips containing CPO technology and that related core components are still in the collaborative research and design phase, with no business revenue generated yet [1] Business Development - The LPO business has sent samples for testing to several major North American customers, but the cumulative orders and shipment amounts for the first half of 2025 are expected to account for only about 0.03% of the company's revenue during the same period, contributing minimally to current performance [1] Investor Guidance - Investors are advised to view the company's progress in emerging technology fields rationally and not to overinterpret the impact of related businesses on short-term performance, while also being aware of the uncertainties associated with business implementation [1] Shareholder Activity - On August 27, 2025, the company's controlling shareholder, Cambridge Industries Company Limited, reduced its holdings by 1.8 million shares through a block trade [1]